<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Kris Flinn

Analyst, Wound Care - 20+ years of experience within wound care including Smith & Nephew. Recently ran a consultancy focusing on assisting med device companies with commercial strategies. Kris is based in England.

Wound Care

Could Enhanced Collagen Offer a New Solution in Skin Substitutes?

SmartTRAK interviews two HYFACOL Limited executives about their collagen manufacturing platform, HyFaCol...

Wound Care

Advocacy in Wound Care: An Interview with the Alliance of Wound Care Stakeholders

SmartTRAK interviews two leaders from the Alliance of Wound Care Stakeholders to discuss its aim to be t...

Wound Care

Impact of the OPPS Reimbursement Rules on the US Advanced Wound Care Market

Wound GM Kris Flinn and Senior Analysts Elizabeth Anderson and Jay Merkel discuss the impact of the fina...

Wound Care

Impact of Final Physician Fee Schedule on US Skin Substitutes in 2026

Wound GM Kris Flinn and Senior Analysts Elizabeth Anderson and Jay Merkel discuss the impact of the fina...

Wound Care

CMS Proposes Major Changes to Skin Substitutes Reimbursement: What You Need to Know

SmartTRAK's industry experts discuss CMS’ proposed changes to skin substitutes reimbursement and their p...

Wound Care

Impact of LCD Postponement on the US Skin Substitutes Market

Wound GM Kris Flinn and Senior Analysts Elizabeth Anderson and Jay Merkel discuss the impact of delay an...

Wound Care

Artificial Intelligence in Wound Diagnostics: Four Companies to Watch in 2025

SmartTRAK highlights four wound diagnostics companies utilizing artificial intelligence to watch in 2025...

Wound Care

UK Market Growth Undermined by Advanced Dressings Challenges

SmartTRAK reports from the recent Wounds UK conference and discovers optimistic resilience in the face o...

Wound Care

Polaroid Therapeutics: Start-Up Spotlight

Antimicrobial resistance (AMR) was directly responsible for 1.27 million deaths worldwide in 2019, accor...

Wound Care

What Impact will GLP-1 Agonists have on Chronic Wounds?

With many believing that GLP-1 agonists should be considered a “wonder drug,” SmartTRAK explores what im...